DexCare Acquires Mila Health to Combine Access Data with AI Coordination
DexCare, a healthcare access platform, acquired Mila Health, an AI care coordination company, on September 21, 2026. The deal merges DexCare's access data model with Mila's conversational AI to manage the full patient access continuum. Financial terms were not disclosed, but the acquisition is DexCare's second after its 2022 purchase of Womp.
DexCare was incubated inside Providence Health's digital innovation group in 2016 and spun out as an independent company in 2021, having raised $146 million including a $75 million Series C led by ICONIQ Growth. Its platform serves 57 million patients across all 50 states, with clients including Kaiser Permanente, Piedmont, Texas Health Resources, and Tampa General Hospital. Mila Health launched in January 2024 under CEO Shailu Verma, a former UnitedHealth Group and Amazon Web Services product leader, and scaled across payers, health systems, and more than 300 dental organizations.
The combined platform unites DexCare's scheduling rules engine and EHR integrations—validated through over 10 million completed bookings—with Mila's autonomous voice, SMS, and web chat agents. Reported operational gains include a 40 percent increase in appointments booked on fixed capacity, a five-day reduction in time-to-care, a 54 percent outbound patient response rate, and no-show rates cut in half. This marks DexCare's second acquisition, following its 2022 purchase of Womp.
This merger could meaningfully alter how patients experience healthcare navigation, potentially reducing scheduling friction, referral delays, and missed appointments through AI-driven coordination. Health systems may gain efficiency and revenue capture, while patients could see faster access to care. However, reliance on autonomous conversational agents raises questions about data privacy, algorithmic clinical routing, and whether less digitally comfortable patients might face barriers. With a footprint spanning 57 million patients, the platform's scale suggests real impact, though outcomes will depend on governance and equitable deployment.